Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
PROVECTUS BIOPHARMACEUTICALS, INC. | 10%+ Owner | Common Stock | 12M | Aug 12, 2024 | Direct | ||
PROVECTUS BIOPHARMACEUTICALS, INC. | 10%+ Owner | Common Stock | 6.5M | Aug 12, 2024 | By IRA | ||
PROVECTUS BIOPHARMACEUTICALS, INC. | 10%+ Owner | Series D-1 Convertible Preferred Stock | 4.26M | Aug 12, 2024 | Direct | ||
PROVECTUS BIOPHARMACEUTICALS, INC. | 10%+ Owner | 8% Secured Convertible Promissory Note | 245K | Aug 11, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PVCT | PROVECTUS BIOPHARMACEUTICALS, INC. | Aug 12, 2024 | 1 | $756K | 4 | Aug 14, 2024 | 10%+ Owner |
PVCT | PROVECTUS BIOPHARMACEUTICALS, INC. | Aug 11, 2023 | 1 | $700K | 4 | Aug 14, 2023 | 10%+ Owner |
PVCT | PROVECTUS BIOPHARMACEUTICALS, INC. | May 8, 2023 | 1 | $540K | 4 | May 9, 2023 | 10%+ Owner |
PVCT | PROVECTUS BIOPHARMACEUTICALS, INC. | Mar 27, 2023 | 0 | $0 | 3 | Mar 28, 2023 | 10%+ Owner |